4Menges M, Lerch MM, Zeitz M. The double duct sign in patients with malignant and benign pancreatic lesions[J]. Gastrointest Endosc,2000,52(1):74-77.
5Friess H, Langhans J, Ebert M, et al. Diagnosis of pancreatic cancer by 2 [18F]-fluoro-2-deoxy-D-glucose positron emission tomography [J]. Gut,1995,36 (5):771- 777.
6Heinrich S, Goerres GW, Schafer M, et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its costeffectiveness[J]. Ann Surg,2005,242(2):235-243.
7Yusuf TE, Ho S, Pavey DA, et al. Retrospective analysis of the utility of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in pancreatic masses, using a 22- gauge or 25-gauge needle system: a muhicenter experience[J]. Endoscopy,2009,41 (5):445-448.
8Chang KJ. State of the art lecture: endoscopic ultrasound (EUS) and FNA in pancreatico-biliary tumors [J]. Endoscopy, 2006,38(Suppl 1):S56-S60.
9Bournet B, Souque A, Senesse P, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis [J]. Endoscopy, 2009,41(5):552-557.
10Beger HG, Schlosser W, Friess HM, et al. Duodenumpreserving head resection in chronic pancreatitis changes the natural course of the disease: a single-center 26-year experience[J]. Ann Surg,1999,230(4):512-519.
